Publications by authors named "Jon Rosen"

Claim this Profile
A
Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics.
Rituparna Bhattacharya, Raymond A Harvey, Keli Abraham, Jon Rosen, Paul Mehta

Amyotroph Lateral Scler Frontotemporal Degener· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymmetric synthesis of highly functionalized tetrahydropyran DPP-4 inhibitor.
Feng Xu, Michael J Zacuto, Yoshinori Kohmura, Jon Rosen, Andrew Gibb

Org Lett· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and characterization of an inhibitor of glucosylceramide synthase.
Steven Richards, Christopher J Larson, Elena S Koltun, Art Hanel, Vicky Chan, Jon Rosen

J Med Chem· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a new class of glucosylceramide synthase inhibitors.
Elena Koltun, Steven Richards, Vicky Chan, Jason Nachtigall, Hongwang Du, Jon Rosen

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual differentiation of the spinal nucleus of the bulbocavernosus is not mediated solely by androgen receptors in muscle fibers.
Lee Niel, Amit H Shah, Gareth A Lewis, Kaiguo Mo, Diptendu Chatterjee, Jon Rosen

Endocrinology· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.
Connie L Erickson-Miller, Evelyne Delorme, Shin-Shay Tian, Christopher B Hopson, Amy J Landis, Jon Rosen

Stem Cells· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LGD-5552, an antiinflammatory glucocorticoid receptor ligand with reduced side effects, in vivo.
Francisco J López, Robert J Ardecky, Bruce Bebo, Khalid Benbatoul, Louise De Grandpre, Jon Rosen

Endocrinology· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-specific activation of the human skeletal alpha-actin by androgens.
Mei Hua Hong, Hong Sun, Cheng He Jin, Mark Chapman, Junlian Hu, Jon Rosen

Endocrinology· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profile.
Jeffrey N Miner, Bob Ardecky, Khalid Benbatoul, Kimberly Griffiths, Christopher J Larson, Jon Rosen

Proc Natl Acad Sci U S A· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An orally active selective androgen receptor modulator is efficacious on bone, muscle, and sex function with reduced impact on prostate.
Jeffrey N Miner, William Chang, Mark S Chapman, Patricia D Finn, Mei Hua Hong, Jon Rosen

Endocrinology· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist.
Connie L Erickson-Miller, Evelyne DeLorme, Shin-Shay Tian, Christopher B Hopson, Kenneth Stark, Jon Rosen

Exp Hematol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects.
Michael J Coghlan, Peer B Jacobson, Ben Lane, Masaki Nakane, Chun Wei Lin, Jon Rosen

Mol Endocrinol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective binding and oligomerization of the murine granulocyte colony-stimulating factor receptor by a low molecular weight, nonpeptidyl ligand.
Michael L Doyle, Shin-Shay Tian, Stephen G Miller, Linda Kessler, Audrey E Baker, Jon Rosen

J Biol Chem· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear hormone receptor assays for drug discovery.
Jon Rosen, Keith Marschke, Deepa Rungta

Curr Opin Drug Discov Devel· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nonsteroidal glucocorticoid receptor antagonist.
Jeffrey N Miner, Curtis Tyree, Junlian Hu, Elaine Berger, Keith Marschke, Jon Rosen

Mol Endocrinol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a pharmacophore for thrombopoietic activity of small, non-peptidyl molecules. 1. Discovery and optimization of salicylaldehyde thiosemicarbazone thrombopoietin mimics.
Kevin J Duffy, Anthony N Shaw, Evelyne Delorme, Susan B Dillon, Connie Erickson-Miller, Jon Rosen

J Med Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a pharmacophore for thrombopoietic activity of small, non-peptidyl molecules. 2. Rational design of naphtho[1,2-d]imidazole thrombopoietin mimics.
Kevin J Duffy, Alan T Price, Evelyne Delorme, Susan B Dillon, Celine Duquenne, Jon Rosen

J Med Chem· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis